# FDA Inspection 1244089 - Naval Daver, M.D. - July 18, 2024

Source: https://www.keypedia.com/records/fda_inspections/naval-daver-md/88d648fd-63b5-460b-acb0-5aef380f9ab0
Source feed: FDA_Inspections

> FDA Inspection 1244089 for Naval Daver, M.D. on July 18, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1244089
- Company Name: Naval Daver, M.D.
- Inspection Date: 2024-07-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1297496 - 2025-12-19](https://www.keypedia.com/records/fda_inspections/naval-daver-md/fbd4c393-0936-44a3-961e-ac82364be362)
- [FDA Inspection 1297496 - 2025-12-19](https://www.keypedia.com/records/fda_inspections/naval-daver-md/ab977831-7ae5-4f78-b77a-db47de044262)

Company: https://www.keypedia.com/companies/naval-daver-md/5b1b3282-f570-4451-86e2-6587233d397e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c